Skip to content

Checked

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 1
Interventional
Planned enrollment
171
Participants, all sites
U.S. sites
38
In 25 states

Study details

Conditions
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar, NPM1 Mutation, MLL Rearrangement, Leukemia, Acute Myeloid Leukemia
Sponsor
Kura Oncology, Inc. (Industry)
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Start
02/22/2024
Primary completion (expected)
December 2026
Last updated by sponsor
08/20/2026

Full eligibility rules, contacts and site names: NCT06001788 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Arizona: Gilbert
  • California: Los Angeles (2), Orange, San Francisco
  • Colorado: Denver
  • Connecticut: New Haven
  • Georgia: Atlanta, Augusta
  • Illinois: Chicago, Maywood, Springfield
  • Iowa: Iowa City
  • Kansas: Kansas City
  • Massachusetts: Boston
  • Michigan: Detroit (2)
  • Missouri: St Louis
  • Nebraska: Omaha
  • New Jersey: Hackensack
  • New York: New York (2), Buffalo, Lake Success, Rochester, Stony Brook
  • North Carolina: Charlotte
  • Ohio: Cleveland
  • Oklahoma: Oklahoma City
  • Pennsylvania: Allentown
  • South Carolina: Greenville
  • Tennessee: Nashville
  • Texas: Dallas, Houston
  • Vermont: Burlington
  • Virginia: Charlottesville
  • Washington: Seattle
  • Wisconsin: Milwaukee

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 08/20/2026